Genelux (GNLX) Retained Earnings (2022 - 2026)
Genelux's (GNLX) quarterly Retained Earnings came in at -$5000.0 in Q1 2026, down 155.56% quarter-over-quarter from $9000.0 in Q4 2025.
Genelux (GNLX) Retained Earnings (2022 - 2026) Analysis & Trends
Genelux's Retained Earnings history runs 5 years deep, the most recent figure standing at -$5000.0 for Q1 2026.
- On a quarterly basis, Retained Earnings changed N/A year-over-year to -$5000.0 in Q1 2026; TTM through Mar 2026 was -$5000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $9000.0, up 100.0% from the prior year.
- Retained Earnings fell to -$5000.0 in Q1 2026 per GNLX's latest filing, from $9000.0 in the prior quarter.
- Across five years, Retained Earnings topped out at $290.6 million in Q2 2025 and bottomed at -$251.4 million in Q4 2024.
- The 5-year median for Retained Earnings is $154.4 million (2022), against an average of $111.8 million.
- Biggest YoY gain for Retained Earnings was 13789000.0% in 2024; the steepest drop was 204.14% in 2024.
- Year by year, Retained Earnings stood at $154.4 million in 2022, then jumped by 56.34% to $241.4 million in 2023, then tumbled by 204.14% to -$251.4 million in 2024, then jumped by 100.0% to $9000.0 in 2025, then plunged by 155.56% to -$5000.0 in 2026.
- Per Business Quant, the three latest GNLX Retained Earnings figures stand at -$5000.0 (Q1 2026), $9000.0 (Q4 2025), and $8000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | -27.89 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -279.01 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 12.91 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -622,000.00 |
| 10 | Genelux | 129.36 Mn | 129.36 Mn | - | -5,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5,000.00 |
| Dec 31, 2025 | 9,000.00 |
| Sep 30, 2025 | 8,000.00 |
| Jun 30, 2025 | 290.63 Mn |
| Dec 31, 2024 | -251.39 Mn |
| Sep 30, 2024 | 275.78 Mn |
| Jun 30, 2024 | 274.03 Mn |
| Mar 31, 2024 | 244.87 Mn |
| Dec 31, 2023 | 241.39 Mn |
| Sep 30, 2023 | 2,000.00 |
| Dec 31, 2022 | 154.40 Mn |